Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus EMS vs Prograf in Renal Transplant
NCT01244659Phase 3Withdrawn
- Sponsor
- EMS
- Start
- May 2014
- Primary completion
- Aug 2014
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in kidney transplant rejection, sponsored by EMS. Planned start May 2014; status: withdrawn.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01244659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244659.